Patients With Psoriatic Arthritis Who Are Not Eligible for Randomised Controlled Trials for TNF Inhibitors Have Treatment Response and Drug Survival Similar to Those Who Are Eligible

RMD Open - United Kingdom
doi 10.1136/rmdopen-2019-000984

Related search